These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16761129)

  • 21. Attentional control and brain metabolite levels in methamphetamine abusers.
    Salo R; Nordahl TE; Natsuaki Y; Leamon MH; Galloway GP; Waters C; Moore CD; Buonocore MH
    Biol Psychiatry; 2007 Jun; 61(11):1272-80. PubMed ID: 17097074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of d,l-methamphetamine on simulated driving performance.
    Silber BY; Croft RJ; Downey LA; Camfield DA; Papafotiou K; Swann P; Stough C
    Psychopharmacology (Berl); 2012 Feb; 219(4):1081-7. PubMed ID: 21842157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.
    Stough C; King R; Papafotiou K; Swann P; Ogden E; Wesnes K; Downey LA
    Psychopharmacology (Berl); 2012 Apr; 220(4):799-807. PubMed ID: 22020992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers.
    Gustavsen I; Mørland J; Bramness JG
    Accid Anal Prev; 2006 May; 38(3):490-5. PubMed ID: 16343411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond drug effects and dependent variables: the use of the Poisson-Erlang model to assess the effects of D-amphetamine on information processing.
    Halliday R; Gregory K; Naylor H; Callaway E; Yano L
    Acta Psychol (Amst); 1990 Feb; 73(1):35-54. PubMed ID: 2180255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.
    Lamers CT; Ramaekers JG; Muntjewerff ND; Sikkema KL; Samyn N; Read NL; Brookhuis KA; Riedel WJ
    J Psychopharmacol; 2003 Dec; 17(4):379-87. PubMed ID: 14870949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.
    Yasar S; Gaal J; Justinova Z; Bergman J
    Psychopharmacology (Berl); 2005 Oct; 182(1):95-103. PubMed ID: 15990999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects.
    Pietrzak RH; Snyder PJ; Maruff P
    Schizophr Res; 2010 Dec; 124(1-3):176-82. PubMed ID: 20947305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are attention lapses related to d-amphetamine liking?
    McCloskey M; Palmer AA; de Wit H
    Psychopharmacology (Berl); 2010 Feb; 208(2):201-9. PubMed ID: 19936714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between ethanol and dextroamphetamine: effects on psychomotor performance.
    Perez-Reyes M; White WR; McDonald SA; Hicks RE
    Alcohol Clin Exp Res; 1992 Feb; 16(1):75-81. PubMed ID: 1558306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions.
    Chudasama Y; Nathwani F; Robbins TW
    Behav Brain Res; 2005 Mar; 158(1):97-107. PubMed ID: 15680198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of single-dose Ginkgo biloba and Panax ginseng on driving performance.
    LaSala GS; McKeever RG; Patel U; Okaneku J; Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2015 Feb; 53(2):108-12. PubMed ID: 25597699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of d-amphetamine in human models of information processing and inhibitory control.
    Fillmore MT; Kelly TH; Martin CA
    Drug Alcohol Depend; 2005 Feb; 77(2):151-9. PubMed ID: 15664716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.